Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
about
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer inductionSecond malignant neoplasms and cardiovascular disease following radiotherapy.Collaborative Research in Childhood Cancer Survivorship: The Current LandscapeSubsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor StudyTherapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.Methodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy.Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review.Epidemiology of therapy-related myeloid neoplasms after treatment for pediatric acute lymphoblastic leukemia in the nordic countries.Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence.Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivorsTherapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology GroupRadiation associated tumors following therapeutic cranial radiationSecondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study.Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor StudyChildhood leukaemia: long-term excess mortality and the proportion 'cured'.Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.Successful coordination and execution of nontherapeutic studies in a cooperative group setting: lessons learned from Children's Oncology Group studies.Solid cancers after allogeneic hematopoietic cell transplantationHigh-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 studySecond neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.Secondary malignancies across the age spectrum.Radiation-induced meningiomas: a shadow in the success story of childhood leukemiaTherapy-related myelodysplasia and acute myeloid leukemiaSalivary gland tumours as second neoplasms: two cases and literature review.Acute leukemia in women.Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.Late effects of childhood leukemia therapy.Therapy-related myelodysplastic syndrome.Risk and survival outcomes of radiation-induced CNS tumors.Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesisAntagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience.Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study.Risk of subsequent malignancies in survivors of childhood leukemia.Childhood secondary ALL after ALL treatment.
P2860
Q24567501-BFAC0F8B-CC3F-4D17-B04E-EC99D615D30DQ26864522-BD39790E-3FBA-42D7-A019-0AD295E3C8CCQ28081135-DF031481-6E99-4C0C-BE95-0EC554F05A5BQ34008980-B7B70D6F-266F-43B7-8C90-CE0BB686B7F0Q34267862-F18F1E11-F7D3-44E9-BCCC-67E979EB882EQ34366619-5C41BA63-1056-4547-88E8-F4D1EE1FA5E3Q34788603-8C68F01E-4867-4F70-9902-8E04CCA2F083Q35040001-8E7E1C8A-1FFC-4AC0-BE32-5454E192E882Q35117677-C3423E4E-0803-4C3A-93B7-C0E612A8E8CDQ35183788-8B87644F-9F78-4888-9E79-CF32571C7F82Q35327266-372AA2AB-9BF9-4489-A4BD-AB989D406933Q35615792-9E0DBCF4-846D-4D46-BCE0-05BEB443D970Q35975367-4B64016F-EED0-4056-B618-F77215B3E38BQ35976536-436C3E08-A49D-45A6-A2E7-A357760ABC06Q36194631-436C2FC3-45BF-41F6-9426-0403E3E4F1CDQ36372608-97E2CF75-96A1-4A5D-8F1F-F1AD100DF1C9Q36384739-416C4CBE-886A-4C3A-8617-2B84A2CA6BA4Q36713502-A12428AD-54CB-4F25-9C6D-E1437B6E4709Q36755145-CC8CA02A-705A-4BCF-86A7-AC3F4876CFC4Q36898355-4C7B8B4B-3605-4966-88DA-2AE3B1B02CFBQ36990089-A2BAB464-865C-4345-B965-D108A8E43CF9Q37082013-AFEB559D-7A12-4293-AC86-AE0A7F26B61CQ37181695-40F0F72D-5D9C-4030-90F3-76544D1293B1Q37234604-A707986B-FFDA-4CFA-8BD1-56767389E0A3Q37334838-AC914E52-AF84-4EC7-AD2E-0748E8BBDE00Q37379773-0D96C864-4964-40A0-BFD4-AE5D07E672A3Q37395358-5B64CF99-6EC8-4AA7-AE15-32730C4C84CAQ37402657-530815A6-EAC6-44C6-BEAB-F701ADAB15B7Q37634631-D93009A1-3857-41CF-A1F5-18AD6F676B92Q37699362-6AEEEC8A-0A41-4F9E-8BB9-BBFA0B30D571Q37792821-4DC00A2B-66B3-4573-B11C-6C0C5C80D563Q37892981-FFF645D1-56A6-43B9-AC68-F439EC2F0A12Q38353167-2DD29646-AD81-4359-BFC3-30B86A17EDAFQ38840856-55F3FDAE-9097-4460-A71A-A0128916575EQ39444659-DC98A310-E886-4F1B-8267-6FE77700920FQ40262230-1CEF12D8-C061-42CA-BB28-0F05BE584F4CQ40345824-6064BB7A-73B5-46CF-BE9A-CF7A85560088Q44546239-7D2EC098-5061-4CA3-A689-56383A6C3FB8Q45854743-A08FEECD-32E5-4352-A03C-EAA70F806060Q47289626-9C4912C9-90F5-446E-85A3-4ABD9D96BE6F
P2860
Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Low incidence of second neopla ...... hoblastic leukemia after 1983.
@en
Low incidence of second neopla ...... hoblastic leukemia after 1983.
@nl
type
label
Low incidence of second neopla ...... hoblastic leukemia after 1983.
@en
Low incidence of second neopla ...... hoblastic leukemia after 1983.
@nl
prefLabel
Low incidence of second neopla ...... hoblastic leukemia after 1983.
@en
Low incidence of second neopla ...... hoblastic leukemia after 1983.
@nl
P2093
P1433
P1476
Low incidence of second neopla ...... hoblastic leukemia after 1983.
@en
P2093
Harland N Sather
Leslie L Robison
Michael E Trigg
Olga B Pabustan
Smita Bhatia
P304
P356
10.1182/BLOOD.V99.12.4257
P407
P577
2002-06-01T00:00:00Z